dc.contributor.author | Ezel, Tasdemir | |
dc.contributor.author | Kocyigit, Yuksel | |
dc.contributor.author | Deveci, Engin | |
dc.contributor.author | Atamer, Yildiz | |
dc.contributor.author | Sermet, Abdurrahman | |
dc.contributor.author | Uysal, Ersin | |
dc.contributor.author | Aktas, Ayfer | |
dc.date.accessioned | 2024-04-24T17:47:56Z | |
dc.date.available | 2024-04-24T17:47:56Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 0884-6812 | |
dc.identifier.uri | https://hdl.handle.net/11468/22817 | |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sci Printers & Publ Inc | en_US |
dc.relation.ispartof | Analytical and Quantitative Cytopathology and Histopathology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Angiogenesis Inhibitors | en_US |
dc.subject | Antihypertensive Agents | en_US |
dc.subject | Diabetes Complications | en_US |
dc.subject | Diabetes Insipidus | en_US |
dc.subject | Nephrogenic | en_US |
dc.subject | Diabetes Mellitus | en_US |
dc.subject | Diabetic Kidney Disease | en_US |
dc.subject | Diabetic Nephropathy | en_US |
dc.subject | Gliclazide | en_US |
dc.subject | Hypoglycemic Agents | en_US |
dc.subject | Losartan | en_US |
dc.subject | Resveratrol | en_US |
dc.title | Biochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat Model | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 37 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 187 | en_US |
dc.identifier.endpage | 198 | en_US |
dc.department | Dicle Üniversitesi | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.wos | WOS:000356990200006 | en_US |
dc.identifier.pmid | 26173356 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |